Filing Details

Accession Number:
0001209191-12-011830
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-21 18:00:58
Reporting Period:
2012-02-16
Filing Date:
2012-02-21
Accepted Time:
2012-02-21 18:00:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA Pharmaceutical Preparations (2834) 030491827
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1506314 Patrick James Kelly 9605 Medical Center Drive
Suite 300
Rockville MD 20850
Svp, Cfo, Sec & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-16 12,500 $0.00 17,500 No 4 M Direct
Common Stock Disposition 2012-02-16 4,920 $4.67 12,580 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2012-02-16 12,500 $0.00 12,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,500 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
  2. This transaction was executed in multiple trades at prices ranging from $4.63 to $4.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The Restricted Stock Units vest in four equal annual installments beginning January 1, 2012. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
  4. N/A